Hypothermic Perfusion Preservation Market Size, Share & Trends Analysis Report By End Users (Hospitals, Organ Procurement Organizations (OPOs), Transplant Centres), By Organ Type (Heart, Lungs, Live, Kidneys, Others), By Region, And By Segment Forecasts, 2023-2031
Hypothermic Perfusion Preservation Market Size is predicted to represent a 10.26% CAGR during the forecast period for 2023-2031.
The Hypothermic Perfusion Preservation Market refers to the industry that revolves around the use of hypothermic perfusion preservation techniques for the storage and transportation of organs intended for transplantation. This market is dynamic, driven by continuous research, technological advancements, and the rising global demand for efficient organ preservation techniques. Furthermore, the ongoing increase in healthcare expenditures in both developed and developing nations is a key factor contributing to the expansion of the hypothermic perfusion preservation market. Substantial investments in healthcare infrastructure, including specialized facilities for organ transplants, have facilitated the adoption of advanced preservation techniques, making a significant contribution to market growth.
However, the initial investment and continuous operational costs associated with hypothermic perfusion preservation devices are considerably high. Financial challenges stem from the expenses related to procuring and maintaining the equipment, as well as acquiring specialized preservation solutions. This economic burden poses a significant obstacle to the widespread adoption of these technologies, particularly in healthcare settings with limited resources
Competitive Landscape
Some Major Key Players In The Hypothermic Perfusion Preservation Market:
- Organ Recovery Systems
- XVIVO Perfusio
- Paragonix Technologie
- TransMedics
- Bridge to Life Ltd
- Preservation Solutions Inc.
- OrganOx
- Organ Assist
- Waters Medical Systems LLC
- Preservation Sciences Inc.,
- 21st Century Medicine (US),
- Shanghai Genext Medical Technology (China)
- Carnamedica (Poland),
- Transplant Biomedicals (Spain),
- Institut Georges Lopez (France),
- Global Transplant Solutions (US),
- Bridge to Life Limited (US)
- Avionord
- Others
Market Segmentation:
The hypothermic perfusion preservation market is segmented on the basis of end users and organ type. Based on end users, the hypothermic perfusion preservation market is segmented into hospitals, organ procurement organizations (OPOs), and transplant centres. By organ type, the market is segmented into heart, lungs, liver, kidneys, and others.
Based On End-Users, The Transplant Centres Segment Is A Major Contributor In The Hypothermic Perfusion Preservation Market.
The transplant centres category is expected to hold a major share of the global Hypothermic Perfusion Preservation market in 2022. Specialized centres necessitate sophisticated preservation techniques to guarantee the viability of organs during their transportation and transplantation. Additionally, the increasing incidences of chronic diseases and organ failures have heightened the demand for effective organ preservation, leading to the widespread adoption of hypothermic perfusion preservation systems in transplant centres. This surge in adoption is contributing to the rapid growth of this segment.
The Kidney Segment Witnessed Growth At A Rapid Rate.
The kidney segment is projected to grow at a rapid rate in the global hypothermic perfusion preservation market. Because of the widespread occurrence of end-stage renal disease and the consequent global demand for kidney transplants, there is an increased necessity for effective preservation techniques. The rising prevalence of conditions like diabetes and hypertension, which can result in kidney failure, has further heightened the demand. Moreover, the notable progress in hypothermic perfusion preservation technology has notably enhanced the success rates of kidney transplantation, solidifying the dominance of the kidney segment in the market.
In The Region, The North American Hypothermic Perfusion Preservation Market Holds A Significant Revenue Share.
The North America Hypothermic Perfusion Preservation market is expected to register the highest market share. In North America, increased investments in healthcare, including specialized facilities for organ transplants, have fostered the adoption of advanced preservation techniques. This positive trend has led to substantial growth in the market, reflecting a commitment to ensuring the effectiveness of organ transplantation procedures. In addition, Asia Pacific is estimated to grow at a rapid rate in the global hypothermic perfusion preservation market. Ongoing research, continuous technological advancements, and a growing demand for efficient organ preservation techniques characterize the market in APAC.
Recent Developments
- In Aug 2023, Specific assets of Bridge to Life Ltd. (BTL) were sold to TransMedics, Inc. BTL intends to concentrate on its primary preservation solutions business and its forthcoming Food and Drug Administration (FDA) application for the VitaSmart™ Liver Machine Perfusion System with the funds obtained from the sale of these assets.
- In July 2021, TransMedics Group, Inc. received authorization from the U.S. FDA for their OCS™ Lung Solution to be used in transplants involving cold storage procedures. The solution, a constituent of the company's OCS Lung System, is used for hypothermic flushing, storage, and transportation of donor lungs for transplantation.
Hypothermic Perfusion Preservation Market Report Scope
| Report Attribute | Specifications |
| Growth Rate CAGR | CAGR of 10.26% from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By End-Users, Organ Type |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
| Competitive Landscape | Organ Recovery Systems, XVIVO Perfusion, Paragonix Technologies, TransMedics, Bridge to Life Ltd., Preservation Solutions Inc., OrganOx, Organ Assist, Waters Medical Systems LLC, and Preservation Sciences Inc., 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Bridge to Life Limited (US), Avionord, Others |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Hypothermic Perfusion Preservation Market-
Hypothermic Perfusion Preservation Market By End Users
- Hospitals
- Organ Procurement Organizations (OPOs)
- Transplant Centres
Hypothermic Perfusion Preservation Market By Organ Type
- Heart
- Lungs
- Live
- Kidneys
- Others
Hypothermic Perfusion Preservation Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Hypothermic Perfusion Preservation Market Size is predicted to represent a 10.26% CAGR during the forecast period for 2023-2031.
Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Bridge to Life Limited (US), Avionord, Others
End-User and Organ Type are the key segments of the Hypothermic Perfusion Preservation Market.
North American region is leading the Hypothermic Perfusion Preservation Market.